Previous Article | Next Article 
J Virol. 1994 March; 68(3): 1573-1580
Characterization of T-helper epitopes of the glycoprotein of vesicular stomatitis virus.
C Burkhart,
G Freer,
R Castro,
L Adorini,
K H Wiesmüller,
R M Zinkernagel and
H Hengartner
Department of Pathology, Institute for Experimental Immunology, Zürich, Switzerland.
ABSTRACT
The T-helper (Th) cell epitopes in the glycoprotein (GP) of vesicular stomatitis virus serotype Indiana (VSV-IND) were analyzed with a complete panel of overlapping synthetic peptides. Three Th-cell epitopes in C57BL/6 (H-2b) mice and two epitopes in BALB/c (H-2d) mice were defined by their ability to stimulate in vitro proliferation of virus-primed, CD8+ T-cell-depleted spleen cells in a class II-restricted manner. A series of CD4+, I-Ab-restricted T-cell hybridomas from VSV-primed C57BL/6 mice were characterized by their production of interleukin-2 and interleukin-3 upon stimulation with VSV-IND or purified VSV GP in vitro. Of nine hybridomas derived from three independent fusions, five were specific for amino acids (aa) 415 to 433 (p8) of VSV-IND GP, three recognized aa 52 to 71 (p41), and one reacted against aa 316 to 335 (p17). Fluorocytometric analysis of Th hybridomas or VSV-stimulated T-cell lines with monoclonal antibodies specific for the T-cell receptor V beta chain did not reveal obvious correlations between the T-cell receptor V beta gene segment used and the epitope recognized. All three peptides recognized by H-2b mice and both epitopes recognized by H-2d mice which were characterized in primed T-cell populations were capable of activating specific Th cells in vivo as measured by the induction of antibody class switch from immunoglobulin M (IgM) to IgG. Thus, the epitopes are relevant for VSV GP-specific Th response in vivo and are able to provide functional help for the production of anti-VSV-specific neutralizing IgG antibodies.
J Virol. 1994 March; 68(3): 1573-1580
This article has been cited by other articles:
-
Zhou, S., Kurt-Jones, E. A., Fitzgerald, K. A., Wang, J. P., Cerny, A. M., Chan, M., Finberg, R. W.
(2007). Role of MyD88 in Route-Dependent Susceptibility to Vesicular Stomatitis Virus Infection. J. Immunol.
178: 5173-5181
[Abstract]
[Full Text]
-
Scandella, E., Fink, K., Junt, T., Senn, B. M., Lattmann, E., Forster, R., Hengartner, H., Ludewig, B.
(2007). Dendritic Cell-Independent B Cell Activation During Acute Virus Infection: A Role for Early CCR7-Driven B-T Helper Cell Collaboration. J. Immunol.
178: 1468-1476
[Abstract]
[Full Text]
-
Stephens, R., Albano, F. R., Quin, S., Pascal, B. J., Harrison, V., Stockinger, B., Kioussis, D., Weltzien, H.-U., Langhorne, J.
(2005). Malaria-specific transgenic CD4+ T cells protect immunodeficient mice from lethal infection and demonstrate requirement for a protective threshold of antibody production for parasite clearance. Blood
106: 1676-1684
[Abstract]
[Full Text]
-
Homann, D., McGavern, D. B., Oldstone, M. B. A.
(2004). Visualizing the Viral Burden: Phenotypic and Functional Alterations of T Cells and APCs during Persistent Infection. J. Immunol.
172: 6239-6250
[Abstract]
[Full Text]
-
Zhao, Y., Boczkowski, D., Nair, S. K., Gilboa, E.
(2003). Inhibition of invariant chain expression in dendritic cells presenting endogenous antigens stimulates CD4+ T-cell responses and tumor immunity. Blood
102: 4137-4142
[Abstract]
[Full Text]
-
Martinez, I., Rodriguez, L. L., Jimenez, C., Pauszek, S. J., Wertz, G. W.
(2003). Vesicular Stomatitis Virus Glycoprotein Is a Determinant of Pathogenesis in Swine, a Natural Host. J. Virol.
77: 8039-8047
[Abstract]
[Full Text]
-
Flanagan, E. B., Schoeb, T. R., Wertz, G. W.
(2003). Vesicular Stomatitis Viruses with Rearranged Genomes Have Altered Invasiveness and Neuropathogenesis in Mice. J. Virol.
77: 5740-5748
[Abstract]
[Full Text]
-
Flanagan, E. B., Ball, L. A., Wertz, G. W.
(2000). Moving the Glycoprotein Gene of Vesicular Stomatitis Virus to Promoter-Proximal Positions Accelerates and Enhances the Protective Immune Response. J. Virol.
74: 7895-7902
[Abstract]
[Full Text]
-
Maloy, K. J., Burkhart, C., Junt, T. M., Odermatt, B., Oxenius, A., Piali, L., Zinkernagel, R. M., Hengartner, H.
(2000). CD4+ T Cell Subsets during Virus Infection: Protective Capacity Depends on Effector Cytokine Secretion and on Migratory Capability. J. Exp. Med.
191: 2159-2170
[Abstract]
[Full Text]
-
Slifka, M. K., Pagarigan, R. R., Whitton, J. L.
(2000). NK Markers Are Expressed on a High Percentage of Virus-Specific CD8+ and CD4+ T Cells. J. Immunol.
164: 2009-2015
[Abstract]
[Full Text]
-
Oxenius, A., Martinic, M. M. A., Hengartner, H., Klenerman, P.
(1999). CpG-Containing Oligonucleotides Are Efficient Adjuvants for Induction of Protective Antiviral Immune Responses with T-Cell Peptide Vaccines. J. Virol.
73: 4120-4126
[Abstract]
[Full Text]
-
Maloy, K. J., Burkhart, C., Freer, G., Rulicke, T., Pircher, H., Kono, D. H., Theofilopoulos, A. N., Ludewig, B., Hoffmann-Rohrer, U., Zinkernagel, R. M., Hengartner, H.
(1999). Qualitative and Quantitative Requirements for CD4+ T Cell-Mediated Antiviral Protection. J. Immunol.
162: 2867-2874
[Abstract]
[Full Text]
Copyright © 1994 by the American Society for Microbiology. All rights reserved.